Tesla
TSLA
Netflix
NFLX
Disney
DIS
4
Cisco
CSCO
5
Meta Platforms
META
US Stock MarketDetailed Quotes
ZNTL Zentalis Pharmaceuticals
- 1.370
- -0.050-3.52%
Close Apr 29 16:00 ET
98.38MMarket Cap-0.59P/E (TTM)
1.420High1.360Low403.30KVolume1.400Open1.420Pre Close556.08KTurnover0.90%Turnover RatioLossP/E (Static)71.81MShares13.24052wk High0.29P/B61.67MFloat Cap1.01052wk Low--Dividend TTM45.01MShs Float87.190Historical High--Div YieldTTM4.23%Amplitude1.010Historical Low1.378Avg Price1Lot Size
Market Insights
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
FOMC holds rates amid heightened uncertainty: Where will US stocks head next?
🎙️Discussion 1. With the Fed highlighting "elevated uncertainty", are you prioritizing rate projections or near-term economic data for ma
Moo Live
Mar 20 02:25
FOMC Press Conference, March 19, 2025
Zentalis Pharmaceuticals Stock Forum
Zentalis Pharmaceuticals Announces First Patient Dosed in DENALI Part 2 Clinical Trial of Azenosertib in Patients with Cyclin E1+ PROC
Monday, 28th April at 8:00 am
Phase 2 registration-intent trial enrolling Part 2a dose confirmation arms
Topline data from DENALI Part 2 anticipated by year end 2026 with the potential to support an accelerated approval, subject to FDA feedback
SAN DIEGO, April 28, 2025 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc....
Breakthrough: Zentalis Drug Achieves 35% Response Rate Against Hard-to-Treat Ovarian Cancer
$Zentalis Pharmaceuticals (ZNTL.US)$
has options
nfa
$Zentalis Pharmaceuticals (ZNTL.US)$
has options
nfa
a little dilution
1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice.
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free cash flow)
7. NEVER be a blind follower.
LASTLY, If you do...
1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice.
2. Do NOT open position WITHOUT chart confirmation, indicators, momentum.
3. Scale out and secure profits.
4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability.
5. I DO NOT give buy or sell advice
6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free cash flow)
7. NEV...
No comment yet